- Published on
Medicine – Filamentous Fungi: Dermatophytes and Aspergillus Species
1. Introduction to Filamentous Fungi
Filamentous fungi are a group of fungi characterised by the formation of long, branching, thread-like structures called hyphae. Collections of hyphae form a network known as a mycelium, which allows fungi to grow, absorb nutrients and invade suitable tissues.
Filamentous fungi are commonly referred to as moulds. They differ from yeasts, which usually grow as individual round or oval cells and reproduce by budding.
Filamentous fungi are medically important because they cause infections ranging from superficial diseases of the skin, hair and nails to severe invasive infections involving the lungs, blood vessels and other organs.
Two important groups of filamentous fungi are dermatophytes and Aspergillus species.
Dermatophytes primarily infect keratinised tissues, whereas Aspergillus species are environmental moulds capable of producing allergic disease, fungal colonisation and invasive infection.
2. Classification of Filamentous Fungi
Filamentous fungi can be classified according to their morphology, ecological characteristics and clinical manifestations.
Dermatophytes are keratinophilic fungi that infect the skin, hair and nails. They are responsible for dermatophytosis, commonly called ringworm or tinea.
Aspergillus species are environmental moulds that produce airborne conidia. Inhalation of these spores may lead to allergic pulmonary disease, colonisation of pre-existing lung cavities or invasive aspergillosis.
Other medically important filamentous fungi include Mucorales, such as Rhizopus and Mucor, which may cause mucormycosis, particularly in patients with uncontrolled diabetes or severe immunosuppression.
The clinical presentation depends on the fungal species, site of infection and immune status of the host.
Dermatophytes
3. Introduction to Dermatophytes
Dermatophytes are filamentous fungi that cause superficial fungal infections involving keratinised tissues, particularly the skin, hair and nails.
They have the ability to utilise keratin as a nutrient source through the production of keratin-degrading enzymes.
Because dermatophytes primarily depend on keratin, they usually remain confined to the superficial epidermis and its appendages rather than invading deeper tissues.
Infections caused by dermatophytes are collectively called dermatophytosis or tinea.
The term ringworm is commonly used because some infections produce circular skin lesions with raised, scaly borders and central clearing. However, ringworm is caused by fungi rather than parasitic worms.
4. Classification of Dermatophytes
The three classical dermatophyte genera are Trichophyton, Microsporum and Epidermophyton.
Trichophyton species can infect the skin, hair and nails. Important examples include Trichophyton rubrum and Trichophyton tonsurans.
Microsporum species classically infect the skin and hair but generally do not infect nails. An important example is Microsporum canis, which may be transmitted from infected animals.
Epidermophyton species infect the skin and nails but not hair. The classical example is Epidermophyton floccosum.
Modern molecular classification has revised some dermatophyte genera, but these three classical groups remain important for medical examinations.
5. Transmission of Dermatophyte Infections
Dermatophyte infections are transmitted through direct contact with infected individuals, animals or contaminated objects.
Human-to-human transmission may occur through shared towels, clothing, footwear, combs and other personal items.
Animal-to-human transmission is particularly important for certain species, including Microsporum canis, which may be associated with infected cats and dogs.
Dermatophytes can also spread through contaminated environmental surfaces, particularly in communal showers, changing rooms and swimming pool facilities.
Warm, humid environments, excessive sweating, occlusive footwear and skin maceration increase susceptibility to infection.
6. Pathogenesis of Dermatophytosis
Dermatophytes attach to keratinised tissues and produce enzymes that allow them to penetrate and digest keratin.
The fungal hyphae spread within the stratum corneum, hair shafts or nail plates, depending on the species and site of infection.
The host immune response produces inflammation, scaling, itching and erythema.
The degree of inflammation varies according to the fungal species and host immune response.
Infections acquired from animals may provoke more intense inflammation than infections caused by fungi adapted to human hosts.
7. Tinea Corporis
Tinea corporis is a dermatophyte infection involving the skin of the trunk, arms, legs or other non-specialised body surfaces.
It typically produces annular, erythematous, scaly lesions with an advancing border and relative central clearing.
The lesions may be associated with itching and gradually enlarge as fungal growth spreads outward.
The classical ring-shaped appearance gives rise to the term ringworm.
However, not all cases show a perfect ring-shaped pattern, and the appearance may be altered by prior treatment with topical corticosteroids.
8. Tinea Capitis
Tinea capitis is a dermatophyte infection of the scalp and hair shafts.
It occurs predominantly in children and may present with scalp scaling, patchy hair loss, broken hairs and itching.
Some patients develop inflammatory lesions known as kerions, which are boggy, tender swellings caused by an intense inflammatory response to the fungal infection.
Severe inflammatory disease can occasionally result in permanent scarring alopecia.
Because the infection involves the hair follicle and shaft, topical antifungal treatment alone is generally inadequate.
Systemic antifungal therapy is required for tinea capitis, commonly with terbinafine or griseofulvin, depending on the organism and clinical circumstances.
9. Tinea Pedis
Tinea pedis is a dermatophyte infection of the feet, commonly called athlete’s foot.
It frequently affects the spaces between the toes, particularly the fourth and fifth toe webs.
Patients may develop itching, scaling, maceration, fissuring and erythema.
Some infections produce a diffuse, dry, scaly appearance involving the soles and sides of the feet, known as the moccasin distribution.
Tinea pedis is associated with sweating, occlusive footwear and exposure to contaminated communal surfaces.
Treatment usually involves topical antifungal medications and measures to keep the feet dry.
10. Tinea Cruris
Tinea cruris is a dermatophyte infection involving the groin and adjacent upper thighs.
It is commonly referred to as jock itch.
The infection produces erythematous, itchy, scaly plaques, often with a clearly defined advancing border.
The scrotum is usually relatively spared in classical tinea cruris, which can help distinguish it from candidal intertrigo.
Predisposing factors include excessive sweating, obesity, friction, tight clothing and warm, humid conditions.
Topical antifungal treatment is usually effective in uncomplicated cases.
11. Tinea Unguium and Onychomycosis
Tinea unguium refers specifically to dermatophyte infection of the nails.
It is a form of onychomycosis, which is the broader term for fungal nail infection caused by dermatophytes, yeasts or non-dermatophyte moulds.
Affected nails may become thickened, brittle, discoloured and distorted, often with accumulation of keratinous debris beneath the nail plate.
Toenails are more commonly affected than fingernails.
Because the nail plate limits penetration of many topical medications, extensive dermatophyte nail infections often require systemic antifungal treatment.
Oral terbinafine is commonly used for confirmed dermatophyte onychomycosis, provided there are no important contraindications.
12. Tinea Manuum
Tinea manuum is a dermatophyte infection of the hands.
It may cause dry scaling, thickening of the palmar skin, itching and occasionally vesicular lesions.
A characteristic clinical association is two feet–one hand syndrome, in which dermatophyte infection affects both feet and one hand.
This pattern commonly occurs when an individual transfers the fungus from infected feet to the hand.
Treatment involves antifungal medication and management of any associated tinea pedis or nail infection to reduce recurrence.
13. Diagnosis of Dermatophyte Infections
Dermatophyte infections are often suspected from their characteristic clinical appearance.
However, laboratory confirmation is particularly useful when the diagnosis is uncertain, infection is recurrent or systemic antifungal treatment is being considered.
Skin scrapings, hair samples or nail clippings can be examined using potassium hydroxide (KOH) microscopy.
KOH dissolves keratin and allows fungal structures to be visualised more clearly.
Dermatophytes typically appear as branching, septate fungal hyphae.
Fungal culture or molecular testing may be used when species identification or confirmation is necessary.
14. Treatment of Dermatophyte Infections
Treatment depends on the site, severity and extent of infection.
Localised tinea corporis, tinea cruris and tinea pedis can often be treated with topical antifungal agents such as terbinafine or azoles.
Tinea capitis generally requires systemic treatment because the fungus infects the hair shaft and follicle.
Extensive onychomycosis may also require oral antifungal therapy.
Oral terbinafine inhibits fungal squalene epoxidase, disrupting ergosterol synthesis and causing accumulation of toxic squalene within susceptible fungi.
Griseofulvin interferes with fungal mitosis and remains useful for selected dermatophyte infections, particularly certain cases of tinea capitis.
Topical corticosteroids should not be used alone for suspected dermatophyte infection because they may suppress inflammation without eliminating the fungus.
15. Tinea Incognito
Tinea incognito refers to dermatophyte infection whose appearance has been altered by corticosteroid or other immunosuppressive treatment.
Topical corticosteroids may reduce redness and itching temporarily while allowing the fungal infection to persist or spread.
The characteristic raised, scaly border may become less obvious, producing an atypical appearance that resembles eczema or other inflammatory skin disorders.
Recognition is important because continued corticosteroid monotherapy can worsen the infection.
Diagnosis may require KOH microscopy or fungal testing.
Aspergillus Species
16. Introduction to Aspergillus
Aspergillus is a genus of filamentous fungi commonly found in soil, decaying vegetation, dust and other environmental materials.
Aspergillus species produce microscopic airborne spores called conidia, which are frequently inhaled during normal respiration.
In healthy individuals, inhaled spores are usually cleared by respiratory defence mechanisms and immune cells.
However, Aspergillus can cause disease when the host has underlying lung abnormalities, allergic airway disease or impaired immune function.
The most clinically important species is Aspergillus fumigatus, although other species, including Aspergillus flavus, Aspergillus niger and Aspergillus terreus, may also cause infection.
17. Morphological Characteristics of Aspergillus
Aspergillus species typically produce septate hyphae with acute-angle branching, often described as branching at approximately 45 degrees.
This appearance is an important classical histopathological feature.
However, branching angle alone cannot reliably establish the species or distinguish Aspergillus from every other filamentous fungus.
Aspergillus is commonly contrasted with fungi belonging to the order Mucorales, which typically produce broader, ribbon-like, sparsely septate hyphae with irregular branching.
These morphological distinctions are useful in the initial interpretation of tissue specimens.
18. Clinical Manifestations of Aspergillus Infection
Aspergillus can produce several distinct clinical syndromes depending on the host immune response and underlying lung structure.
The three major conditions highlighted in the original notes are allergic bronchopulmonary aspergillosis (ABPA), aspergilloma and invasive aspergillosis.
ABPA represents an exaggerated immune response to Aspergillus antigens within the airways.
Aspergilloma represents the formation of a fungal ball within a pre-existing pulmonary cavity.
Invasive aspergillosis occurs when fungal hyphae invade lung tissue and sometimes blood vessels, producing potentially life-threatening infection.
Chronic pulmonary aspergillosis is another important clinical category, particularly in individuals with pre-existing structural lung disease.
Allergic Bronchopulmonary Aspergillosis
19. Introduction to ABPA
Allergic bronchopulmonary aspergillosis is an immunologically mediated pulmonary disorder caused by hypersensitivity to Aspergillus antigens.
It occurs most commonly in patients with asthma or cystic fibrosis.
In ABPA, Aspergillus may colonise the airways and trigger an exaggerated immune response without necessarily invading the lung tissue.
The resulting inflammation can cause mucus plugging, bronchial obstruction and progressive bronchiectasis.
ABPA is therefore primarily an allergic and inflammatory condition rather than a conventional invasive fungal infection.
20. Pathogenesis of ABPA
ABPA develops when Aspergillus antigens stimulate an excessive immune response in susceptible individuals.
The immune reaction is predominantly associated with type 2 inflammation, including increased IgE production and eosinophilic airway inflammation.
The response involves mechanisms associated with type I hypersensitivity, together with other inflammatory and immune-mediated processes.
Persistent airway inflammation causes mucus hypersecretion, bronchial obstruction and structural airway damage.
Over time, recurrent inflammation may lead to bronchiectasis and deterioration in pulmonary function.
21. Clinical Features of ABPA
Patients with ABPA commonly have a history of asthma or cystic fibrosis.
They may develop worsening wheezing, cough, breathlessness and recurrent episodes of pulmonary deterioration.
Some patients produce thick mucus plugs, which may appear brownish.
Fever, malaise and transient pulmonary infiltrates may also occur.
Recurrent exacerbations can eventually lead to bronchiectasis and chronic respiratory impairment.
A characteristic clinical association is asthma with recurrent pulmonary infiltrates, eosinophilia and markedly elevated total IgE.
22. Diagnosis of ABPA
Diagnosis of ABPA requires integration of clinical features, immunological findings and radiological abnormalities.
Important findings include elevated total serum IgE and evidence of Aspergillus-specific IgE sensitisation.
Peripheral blood eosinophilia may be present, although it can be suppressed by corticosteroid treatment.
Chest imaging may demonstrate bronchiectasis, mucus plugging or transient pulmonary opacities.
High-attenuation mucus on CT is a particularly suggestive finding.
The diagnosis should not be based on total IgE alone because elevated IgE can occur in many other allergic and inflammatory disorders.
23. Treatment of ABPA
The primary goals of treatment are to suppress allergic airway inflammation, improve respiratory symptoms and prevent progressive bronchiectasis.
Systemic corticosteroids are commonly used for acute ABPA because they reduce the inflammatory response.
Oral antifungal therapy, particularly itraconazole, may also be used to reduce Aspergillus burden and antigenic stimulation.
Depending on disease severity and patient characteristics, corticosteroids or itraconazole may be used as initial treatment, while combination therapy is considered in selected situations.
Patients require follow-up of symptoms, pulmonary function, serum IgE trends and imaging findings when appropriate.
Aspergilloma
24. Introduction to Aspergilloma
An aspergilloma is a mass of fungal hyphae, mucus, fibrin and cellular debris that develops within a pre-existing pulmonary cavity.
It is commonly referred to as a fungal ball.
Unlike invasive aspergillosis, a simple aspergilloma usually represents colonisation of an existing cavity without extensive invasion into surrounding lung tissue.
The cavity provides an environment in which inhaled Aspergillus spores can germinate and accumulate.
The most common underlying association is a previous cavitary lung disease, particularly healed pulmonary tuberculosis.
25. Causes and Predisposing Conditions for Aspergilloma
Aspergillomas commonly develop in patients with structural abnormalities of the lungs.
Important predisposing conditions include previous pulmonary tuberculosis, sarcoidosis, bronchiectasis and pre-existing lung cavities caused by other diseases.
Old tuberculous cavities are particularly important because they provide spaces in which Aspergillus can grow.
The fungus forms a compact mass within the cavity rather than necessarily invading normal lung tissue.
Aspergillomas may remain stable for prolonged periods or cause recurrent respiratory complications.
26. Clinical Features of Aspergilloma
Many patients with a simple aspergilloma are asymptomatic, and the lesion is discovered incidentally during chest imaging.
When symptoms occur, they may include chronic cough, sputum production and haemoptysis.
Haemoptysis is the most important clinical complication of aspergilloma.
Bleeding may range from mild blood-streaked sputum to severe, potentially life-threatening pulmonary haemorrhage.
The bleeding occurs because fungal colonisation and associated inflammation can damage blood vessels within or adjacent to the cavity.
27. Radiological Features of Aspergilloma
Chest radiography or CT may demonstrate a rounded soft-tissue mass within a pre-existing pulmonary cavity.
A characteristic feature is a crescent-shaped air space separating the fungal ball from the cavity wall.
This appearance is often called the Monod sign or intracavitary air-crescent sign.
The fungal ball may change position when the patient changes posture, reflecting its mobility within the cavity.
Although this appearance is strongly suggestive of aspergilloma, other intracavitary lesions may produce similar findings.
28. Diagnosis of Aspergilloma
Diagnosis is based on clinical history, characteristic imaging and supportive microbiological or serological findings.
Chest CT is particularly useful for demonstrating the fungal ball and underlying lung cavity.
Aspergillus-specific IgG antibodies may support the diagnosis, especially when chronic pulmonary aspergillosis is suspected.
Fungal culture may identify Aspergillus, but a positive respiratory culture alone does not prove clinically significant disease because environmental colonisation can occur.
Assessment of haemoptysis severity and the underlying lung condition is essential.
29. Treatment of Aspergilloma
Management depends on whether the aspergilloma is asymptomatic, stable or causing complications.
An asymptomatic, stable simple aspergilloma may be managed with observation and appropriate follow-up.
Patients with significant symptoms or recurrent haemoptysis may require intervention.
Surgical resection can be considered for selected patients with symptomatic simple aspergilloma who have adequate pulmonary reserve.
Bronchial artery embolisation may be required to control significant haemoptysis.
Antifungal medications are more important in chronic pulmonary aspergillosis or other forms of progressive disease than in an isolated, stable simple aspergilloma.
Invasive Aspergillosis
30. Introduction to Invasive Aspergillosis
Invasive aspergillosis is a severe fungal infection in which Aspergillus hyphae invade pulmonary tissue and may penetrate blood vessels.
It occurs predominantly in patients with impaired immune defences.
The lungs are the most common initial site because infection usually follows inhalation of airborne Aspergillus spores.
Unlike ABPA or a simple aspergilloma, invasive aspergillosis involves true tissue invasion and can spread to other organs.
It is a potentially life-threatening infection requiring prompt diagnosis and treatment.
31. Risk Factors for Invasive Aspergillosis
Invasive aspergillosis is particularly associated with profound or prolonged neutropenia.
Important risk factors include acute leukaemia, haematopoietic stem-cell transplantation, solid-organ transplantation and prolonged treatment with high-dose corticosteroids.
Patients receiving certain immunosuppressive therapies are also at increased risk.
Invasive aspergillosis can occasionally occur in critically ill patients, including selected individuals with severe influenza or COVID-19, even without classical neutropenia.
The major underlying mechanism is failure of normal immune defences to prevent fungal germination and tissue invasion.
32. Pathogenesis of Invasive Aspergillosis
Inhaled Aspergillus conidia enter the respiratory tract and may reach the alveoli.
In healthy individuals, alveolar macrophages and neutrophils normally eliminate these fungal particles.
When immune defences are impaired, the spores can germinate into hyphae and invade surrounding tissues.
Aspergillus has a characteristic tendency toward angioinvasion, meaning invasion of blood vessel walls.
This can cause vascular thrombosis, tissue infarction, haemorrhage and necrosis.
Bloodstream-associated dissemination may lead to infection of the brain, kidneys, skin and other organs.
33. Clinical Features of Invasive Pulmonary Aspergillosis
Patients may present with persistent fever, cough, breathlessness and pleuritic chest pain.
Haemoptysis may occur when fungal invasion damages pulmonary blood vessels.
In immunocompromised patients, invasive aspergillosis should be considered when fever persists despite appropriate antibacterial treatment.
The clinical presentation may be subtle because severely immunosuppressed individuals may have a reduced inflammatory response.
Rapid progression can result in respiratory failure or disseminated infection.
34. Radiological Features of Invasive Aspergillosis
Chest CT may reveal pulmonary nodules, consolidation, cavitation or other abnormalities.
A classical early finding in some patients is the CT halo sign, in which a pulmonary nodule is surrounded by ground-glass opacity.
The halo may reflect haemorrhage around an area of fungal invasion.
An air-crescent sign can appear during recovery from angioinvasive disease, particularly as neutrophil counts improve.
However, these signs are neither universally present nor specific to Aspergillus infection.
Imaging must therefore be interpreted alongside clinical risk factors and microbiological evidence.
35. Diagnosis of Invasive Aspergillosis
Diagnosis involves a combination of clinical suspicion, imaging, microbiological testing and, when feasible, histopathology.
Bronchoalveolar lavage may be performed to obtain respiratory specimens for fungal culture, microscopy and antigen testing.
Galactomannan is a component of the Aspergillus cell wall that can be detected in serum or bronchoalveolar lavage fluid.
Galactomannan testing is particularly useful in selected high-risk patients, although its sensitivity and specificity vary according to the clinical setting.
Serum β-D-glucan may also support the diagnosis of invasive fungal infection but is not specific for Aspergillus.
Histopathological demonstration of tissue-invasive fungal hyphae provides strong evidence of invasive disease.
36. Treatment of Invasive Aspergillosis
Invasive aspergillosis requires prompt systemic antifungal treatment.
Voriconazole is a major first-line treatment option for invasive aspergillosis.
Isavuconazole is another important option, while liposomal amphotericin B may be used when azoles are unsuitable or in selected clinical circumstances.
Treatment selection depends on the fungal species, disease severity, antifungal susceptibility, organ function and potential drug interactions.
Management also involves reducing immunosuppression when feasible and correcting reversible risk factors.
Because invasive aspergillosis can progress rapidly, treatment should not be delayed when clinical suspicion is high.
37. Voriconazole
Voriconazole is a triazole antifungal agent with strong activity against many Aspergillus species.
It inhibits fungal 14-alpha-demethylase, an enzyme involved in the synthesis of ergosterol.
Ergosterol is an essential component of fungal cell membranes.
Inhibition of ergosterol synthesis disrupts membrane structure and fungal growth.
Important adverse effects include hepatotoxicity, visual disturbances, photosensitivity and numerous drug interactions.
Therapeutic drug monitoring is often used to optimise exposure and reduce toxicity.
38. Amphotericin B
Amphotericin B is a polyene antifungal agent with broad activity against many medically important fungi, including numerous Aspergillus species.
It binds to ergosterol in fungal cell membranes and disrupts membrane integrity.
Liposomal amphotericin B is used in selected severe invasive fungal infections, including invasive aspergillosis when appropriate.
Important adverse effects of amphotericin B include nephrotoxicity, hypokalaemia, hypomagnesaemia and infusion-related reactions.
Liposomal formulations generally have less nephrotoxicity than conventional amphotericin B deoxycholate.
Some Aspergillus species, notably Aspergillus terreus, may be resistant to amphotericin B.
39. Echinocandins
Echinocandins are antifungal drugs that inhibit β-1,3-D-glucan synthase, an enzyme involved in fungal cell wall synthesis.
Important examples include caspofungin, micafungin and anidulafungin.
They are particularly important for invasive candidiasis and have activity against Aspergillus through inhibition of hyphal growth.
However, echinocandins are not generally recommended as sole primary therapy for invasive aspergillosis.
They may be used in selected salvage or combination treatment strategies under specialist guidance.
Comparison of Major Aspergillus Syndromes
40. Allergic Bronchopulmonary Aspergillosis – Clinical Pattern
ABPA occurs primarily in patients with asthma or cystic fibrosis.
The underlying mechanism is hypersensitivity to Aspergillus antigens within the airways rather than invasive fungal growth.
Characteristic findings include worsening asthma symptoms, eosinophilia, elevated total IgE, Aspergillus-specific IgE and bronchiectasis or mucus plugging.
Treatment focuses on controlling inflammation, commonly using systemic corticosteroids, with itraconazole as an important antifungal option.
The key association is asthma + high IgE + eosinophilia + bronchiectasis = consider ABPA.
41. Aspergilloma – Clinical Pattern
Aspergilloma occurs within a pre-existing pulmonary cavity, commonly following previous pulmonary tuberculosis.
The underlying mechanism is fungal colonisation and formation of a compact fungal ball.
The most characteristic symptom is haemoptysis.
Imaging may demonstrate a mobile intracavitary mass surrounded by a crescent of air.
Management depends on symptoms and complications, ranging from observation to surgery or bronchial artery embolisation.
The key association is old tuberculosis cavity + fungal ball + haemoptysis = aspergilloma.
42. Invasive Aspergillosis – Clinical Pattern
Invasive aspergillosis occurs mainly in patients with severe immunosuppression, especially prolonged neutropenia or transplantation.
The underlying mechanism is invasion of pulmonary tissue and blood vessels by fungal hyphae.
Patients may develop persistent fever, cough, pleuritic chest pain, haemoptysis and respiratory deterioration.
CT may reveal nodules with a halo sign, while galactomannan testing and fungal studies may support the diagnosis.
Treatment requires systemic antifungal therapy, commonly voriconazole or isavuconazole.
The key association is neutropenia + persistent fever + pulmonary nodules = consider invasive aspergillosis.
43. Dermatophytes Versus Aspergillus – Note Form
Dermatophytes primarily infect keratinised tissues, including the skin, hair and nails. They produce superficial infections such as tinea corporis, tinea capitis, tinea pedis, tinea cruris and tinea unguium.
Aspergillus species primarily cause respiratory disease following inhalation of environmental conidia, although they can involve other organs.
Dermatophyte infections are usually superficial and are commonly treated with topical or systemic antifungal agents depending on the site.
Aspergillus infections range from allergic airway disease to fungal colonisation and invasive tissue infection.
Dermatophytes are classically associated with ring-shaped scaly skin lesions, whereas Aspergillus is associated with allergic bronchopulmonary disease, pulmonary fungal balls and invasive pulmonary infection.
44. Important Diagnostic Associations
Dermatophyte infection is supported by KOH microscopy showing branching septate hyphae in skin, hair or nail specimens.
ABPA is associated with elevated IgE, Aspergillus sensitisation, eosinophilia and characteristic airway abnormalities.
Aspergilloma is associated with a fungal ball inside a pre-existing lung cavity.
Invasive aspergillosis may be supported by CT abnormalities, galactomannan testing, fungal culture and histopathological evidence of tissue invasion.
Aspergillus typically forms septate hyphae with acute-angle branching, although morphology alone is insufficient for definitive species identification.
45. Important Antifungal Drug Associations
Terbinafine inhibits squalene epoxidase and is particularly important for dermatophyte infections, including selected cases of tinea capitis and onychomycosis.
Griseofulvin interferes with fungal mitosis and is used for selected dermatophyte infections, particularly certain scalp infections.
Itraconazole inhibits ergosterol synthesis and may be used in dermatophyte infections, ABPA and chronic pulmonary aspergillosis.
Voriconazole inhibits ergosterol synthesis and is a major first-line treatment option for invasive aspergillosis.
Isavuconazole is another triazole used in invasive aspergillosis.
Liposomal amphotericin B disrupts fungal cell membranes and is an alternative for selected severe invasive infections.
Echinocandins inhibit fungal cell wall β-glucan synthesis and may have a role in selected salvage or combination treatment strategies for aspergillosis.
Key Clinical Pattern
The most important distinction is that dermatophytes cause superficial infections of keratinised tissues, whereas Aspergillus species can cause allergic, colonising or invasive pulmonary disease.
Dermatophytes → Ringworm/tinea → Skin, hair and nails.
Trichophyton → Skin, hair and nails.
Microsporum → Skin and hair.
Epidermophyton → Skin and nails.
Aspergillus fumigatus → Important cause of ABPA, aspergilloma and invasive aspergillosis.
ABPA → Asthma or cystic fibrosis + elevated IgE + eosinophilia + bronchiectasis.
Aspergilloma → Previous pulmonary cavity, especially after tuberculosis + fungal ball + haemoptysis.
Invasive aspergillosis → Immunosuppression or neutropenia + tissue and vascular invasion + potentially severe pulmonary infection.
For examinations, remember that Aspergillus produces septate hyphae with acute-angle branching, ABPA is primarily a hypersensitivity disorder, aspergilloma represents fungal growth within a pre-existing cavity, and invasive aspergillosis is a serious infection requiring prompt systemic antifungal therapy.